FallberichtOpen Access
Oxaliplatin-Induced Pulmonary Fibrosis: A Rare but Fatal Reality
Cureus · 31.12.2023
DOI: 10.7759/cureus.51411 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 31.12.2023. Verfasst von Kinnera Sahithi Urlapu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Medicine, BronxCare Health System, Bronx, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
chemotherapy side effectsdrug induced interstitial lung diseasedrug-induced pulmonary toxicityfolfoxinterstitial lung diseaseoxaliplatinprogressive ildpulmonary fibrosissteroid therapy
Autor:innen und Institutionen
- Pulmonary Medicine, BronxCare Health System, Bronx, USA.
- Pulmonary and Critical Care, BronxCare Health System, Bronx, USA.
Zitieren
APA
Urlapu, K. S., & Lvovsky, D. (2023). Oxaliplatin-Induced Pulmonary Fibrosis: A Rare but Fatal Reality. Cureus. https://doi.org/10.7759/cureus.51411
Vancouver
Urlapu KS, Lvovsky D. Oxaliplatin-Induced Pulmonary Fibrosis: A Rare but Fatal Reality. Cureus. 2023. doi:10.7759/cureus.51411
BibTeX
@article{Urlapu2023,
author = {Urlapu, Kinnera Sahithi and Lvovsky, Dmitry},
title = {Oxaliplatin-Induced Pulmonary Fibrosis: A Rare but Fatal Reality},
journal = {Cureus},
year = {2023},
doi = {10.7759/cureus.51411}
}
EUVIMED